Kicks-off second-year outdoors with over 18,000 plants slated for fall harvest, confirms 2019 outdoor biomass now in extraction for new cannabis formats at CX Industries
Toronto, Canada, June 12, 2020 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, announced today it completed planting more than 18,000 fully-rooted cannabis plants at its 27-acre outdoor field located adjacent to its modern greenhouse in Strathroy, Ontario. As one of only a handful of licensed-producers entering its second year of outdoor operations, WeedMD also confirmed that its CX Industries extraction hub in Aylmer is now fully operational and extracting cannabinoid-rich, indoor and outdoor-harvested biomass into new cannabis formats.
The Company is producing vapourization (“vape”) cartridges for initial launch this month to WeedMD and Starseed’s medical channels. Additional details will be released about the vape product during its launch week of June 22, 2020. The new products will expand into the adult-use markets by Q3 2020 under WeedMD’s Color Cannabis brand.
“The ability to effectively cultivate cannabis outdoors optimizes our yields for cost-efficient production to develop products with greater commercial sales value,” said Angelo Tsebelis, CEO of WeedMD. “Over the past few months, our cultivation team has made significant headway in boosting outdoor efficiencies, selecting seven optimal outdoor strains and propagating over 18,000 cannabis clones now fully rooted and planted. Additionally, with the ramp up of CX Industries, we are now commercializing our extraction-grade, cannabinoid-rich biomass harvested indoors and outdoors into new cannabis formats starting with vapes to meet our production targets.”
CX Industries. (“CX Industries” or “CX”) is a WeedMD business unit specializing in extraction, toll processing and third-party product formulation from its fully-licensed Aylmer site. With plans to process over 50,000 kgs of biomass annually at peak production, CX offers tolling and white labelling services to other LPs and brands. Two Vitalis Q90 extractors commissioned in late 2019 moved CX Industries into commercial operation in 2020.
WeedMD’s Outdoor Cultivation Highlights
- Over 18,000 fully-rooted cannabis plants comprised from seven strains selected from mother plants shown to excel outdoors in southwestern Ontario.
- Planted in nutrient-rich, natural loamy soil on 27-acre field with irrigation system installed, located directly adjacent to WeedMD’s fully-licensed greenhouse.
- Utilized fertigation formulas prepared by award-winning fertigation supplier Emerald Harvest.
- Optimizing planting methods for this second season, using precision agriculture methods which include crews of under 10 people and a high-performance mechanical planter.
- Planting completed in one-third of the time, with one-third of staffing required compared to 2019.
- All infrastructure and staffing resources onsite with an experienced outdoor-dedicated team.
- A newly-built 50,000 square foot, fully-licensed processing facility strictly for processing and storing outdoor-cultivated biomass in now fully operational processing biomass for CX Industries.
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as CX Industries., a wholly-owned subsidiary which specializes in cannabis extraction from the Company’s fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, along with other employers and union groups complements WeedMD’s direct sales to medical patients. The Company maintains strategic relationships in the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies where adult-use brands Color Cannabis and Saturday are sold.
Follow WeedMD On:
Follow Color Cannabis:
For further information, please contact:
For Investor Enquiries:
KCSA Strategic Communications
For Media Enquiries:
VP, Communications & Corporate Affairs
To learn more, visit us at www.weedmd.com
Forward Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated June 21, 2019 (the “AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE